三利譜(002876.SZ):取得10項專利證書
格隆匯3月10日丨三利譜(002876.SZ)公佈,公司於近日收到中華人民共和國國家知識產權局頒發的10項專利證書,分別為吸附夾具及偏光片清洗機,一種偏光片的生產設備,一種延伸液過濾用樹脂再生及再生時間節點的判定方法,導輥機構,刮水裝置,一種膜材除塵裝置,膜材切邊自動除塵機構及膜材切邊裝置,偏光膜片的拉伸裝置及偏光膜片的製造方法,薄膜拉伸裝置,一種激光加工治具。
上述專利的取得,對公司的生產經營情況不構成重大影響,但有利於進一步確立公司的自主知識產權優勢,並對公司的技術創新、產品創新、市場及品牌影響力提升等方面產生積極的影響,從而提升公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.